STIFTELSEN TIL FREMME AV NORSK APOTEKFARMASI

Operating

Fremme utviklingen av norsk apotekfarmasi. Midlene kan brukes til studier og prosjekter som gjelder rasjonell legemiddelbruk, utvikling og apotekpraksis, kvalitetsutvikling i apotek, og til videre- og etterutdanning innen farmasifaglige områder og eller til andre studier og prosjekter som etter styrets vurdering bidrar til formålet. Økonomisk støtte kan gis til enkeltpersoner, foreninger og virksomheter.

Keywords

civic initiativesprotest movementsenvironmental movementsecological movementsminority groupspatrioticassociationswar veteransconsumer organizationsautomobile associationsrotary clubslodgesyouth organizationsstudent associationsclubs and fraternitiesliterary associationshistorical associationsgarden societiesfilm clubsphotography clubsmusic associationsart associationscraft associationsstamp clubs

Organization

CEO: HP
Hans Petter Heide Johannessen1957
Chairman of the board: KH
Kjell Hermann Halvorsen1977
Years since formation: 24 years; since Sep 5, 2001
Type: Foundation
VAT registered: No
Number of employees: 0

Financials

Total operating income 2024: 187,230,661; NOK
Annual total result 2024: 157,937,186; NOK
Total equity 2024: 1,008,639,193; NOK

Last update: Sep 9, 2025

Management

Management / administration

Name	Role	Shares
HP Hans Petter Heide Johannessen 1957	Managing Director/CEO	-

Board

Name	Role	Shares
PT Per Torgeir Lund 1962	Board Member	-
CK Cecilie Kirsten Wammer Serck-Hanssen 1972	Board Member	-
EM Einar Mathias Teigen Rasch-Halvorsen 1975	Board Member	-
KH Kjell Hermann Halvorsen 1977	Chairman	-
KT Kjersti Tøgard Trøbråten 1966	Board Member	-

Others

Name	Role	Shares
B BDO AS	Auditor	-
A ABACUS RATIO AS	Accountant	-

Last update: Aug 14, 2025

Ownership

Shares owned by the STIFTELSEN TIL FREMME AV NORSK APOTEKFARMASI

Name	Share class	Total number of shares	Share
A APOKUS AS	Ordinary shares	330	66 %
A AS APOTEKERNES HUS	Ordinary shares	223	33.99 %

Last update: Jun 2, 2025

Group structure

STIFTELSEN TIL FREMME AV NORSK APOTEKFARMASI
Total operating income 2024: NOK 187,230,661
Operating profit 2024: NOK 157,937,186
Employees: 0

Financials

in NOK

Summary

Year	2024	2023	2022	2021
Total operating income	187,230,661	126,739,726	-31,330,166	582,404,890
Annual Total Result	157,937,186	106,149,057	-50,175,077	562,569,489
Total assets	1,049,604,815	881,417,470	770,179,875	814,803,263
Total liabilities	40,965,621	30,715,463	25,626,925	20,075,236
Total equity	1,008,639,193	850,702,007	744,552,950	794,728,026

P&L

Year	2024	2023	2022	2021
Total operating income	187,230,661	126,739,726	-31,330,166	582,404,890
Total operating costs	29,293,475	20,590,668	18,844,911	19,835,401
Operating result	157,937,186	106,149,057	-50,175,077	562,569,489
Financial income/costs	0	0	0	0
Profit before tax	157,937,186	0	0	0
Total tax & extraordinary income/cost	0	-106,149,057	50,175,077	-562,569,489
Annual Total Result	157,937,186	106,149,057	-50,175,077	562,569,489

Balance overview

Year	2024	2023	2022	2021
Total fixed assets	11,318,248	11,327,402	11,302,990	11,302,990
Total current assets	1,038,286,567	870,090,067	758,876,885	803,500,273
Total assets	1,049,604,815	881,417,470	770,179,875	814,803,263
Short term debt	40,965,621	30,715,463	25,626,925	20,075,236
Long term debt	0	0	0	0
Total liabilities	40,965,621	30,715,463	25,626,925	20,075,236
Contributed capital	112,087,695	112,087,695	112,087,695	112,087,695
Retained earnings	896,551,498	738,614,312	632,465,255	682,640,331
Total equity	1,008,639,193	850,702,007	744,552,950	794,728,026
Total equity and liabilities	1,049,604,814	881,417,470	770,179,875	814,803,263

Classification

21st company classification

BETA

Small company

STIFTELSEN TIL FREMME AV NORSK APOTEKFARMASI983 525 350